{"organizations": [], "uuid": "89e4e88f3bc61d0d91d55575376aa43a79c00ff7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180122.html", "section_title": "Archive News &amp; Video for Monday, 22 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-beijing-science-sun-pharmaceutical/brief-beijing-science-sun-pharmaceutical-sees-fy-2017-net-profit-to-down-15-pct-to-up-15-pct-idUSL4N1PH30H", "country": "US", "domain_rank": 408, "title": "BRIEF-Beijing Science Sun Pharmaceutical sees FY 2017 net profit to down 15 pct to up 15 pct", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.847, "site_type": "news", "published": "2018-01-22T16:10:00.000+02:00", "replies_count": 0, "uuid": "89e4e88f3bc61d0d91d55575376aa43a79c00ff7"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-beijing-science-sun-pharmaceutical/brief-beijing-science-sun-pharmaceutical-sees-fy-2017-net-profit-to-down-15-pct-to-up-15-pct-idUSL4N1PH30H", "ord_in_thread": 0, "title": "BRIEF-Beijing Science Sun Pharmaceutical sees FY 2017 net profit to down 15 pct to up 15 pct", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-beijing science sun pharmaceutical", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "beijing science sun pharmaceutical co ltd", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 22 (Reuters) - Beijing Science Sun Pharmaceutical Co Ltd\n* Says it sees FY 2017 net profit to decrease by 15 percent to increase by 15 percent, or to be 219.6 million yuan to 297.2 million yuan\n* Says FY 2016 net profit was 258.4 million yuan\n* Comments that expanded market and decreased costs as main reasons for the forecast\nSource text in Chinese: goo.gl/ASu3zu\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/ASu3zu"], "published": "2018-01-22T16:10:00.000+02:00", "crawled": "2018-01-23T18:20:21.014+02:00", "highlightTitle": ""}